Sodium/myo-inositol cotransporter-1 (SMIT-1) is one of the transporters responsible for importing myo-inositol (MI) into the cells. MI is a precursor for a family of signal transduction molecules, phosphatidylinositol, and its derivatives that regulates many cellular functions. SMIT-1 null mice died soon after birth due to respiratory failure, but neonatal lethality was prevented by prenatal maternal MI supplement. Although the lung air sacs were closed, lung development was not significantly affected in the SMIT-1 null mice. The development of the peripheral nerves, including the brachial plexus, facial, vagus, and intercostal nerves, and the phrenic nerve that innervates the diaphragm was severely affected. All of these peripheral nerve abnormalities were corrected by prenatal MI supplement, indicating that MI is essential for the development of peripheral nerve and that neonatal lethality of the SMIT-1 knockout mice is most likely due to abnormal development of the nerves that control breathing. In the adult SMIT-1 deficient mice rescued by MI supplement, MI content in their brain, kidney, skeletal muscle, liver, and sciatic nerve was greatly reduced. The sciatic nerve, in particular, was most dependent on SMIT-1 for the accumulation of MI, and nerve conduction velocity and protein kinase C activity in this tissue were significantly reduced by SMIT-1 deficiency.
signal transduction molecules, inositol-(1,4,5)-triphosphate (IP 3 ), which regulates the release of intracellular calcium stored in endoplasmic reticulum, and diacylglycerol (DAG), an activator of protein kinase C (PKC; refs 7, 8) . Perturbation of inositol metabolism resulting in impaired PKC and Na + /K + -ATPase activities has been postulated as a pathogenic mechanism of diabetic neuropathy (9, 10) . However, the mechanism remains unclear (10, 11) . Cellular MI is thought to originate from three sources: de novo synthesis from glucose by myoinositol-1-phosphate synthase and MI monophosphatase (12) , recycling of phosphatidylinositol, and uptake from extracellular fluid. Dietary MI is an important source of MI. MI in the circulating fluid is taken up by the cells mainly through membrane-associated transporters. The major MI transporter is believed to be the sodium-dependent myo-inositol cotransporter-1 (SMIT-1), which utilizes the electrochemical gradient of Na + across the plasma membrane to import MI, with two Na + coupled to each molecule of MI (13) . SMIT-1 is also called SLC5A3, because it is the third member of the sodium/glucose cotransporter family SLC5 (14) . The mouse SMIT-1 gene is located at the telomeric region of mouse chromosome 16, a region syntenic to human chromosome 21q22, an extra copy of which causes Down syndrome. Indeed, MI levels were found to be elevated in the brains of Down syndrome patients (15) . To determine the physiological functions of SMIT-1 and the consequences of MI depletion, we inactivated the SMIT-1 gene by targeted mutagenesis in mice. Most of the homozygous SMIT-1 knockout mice died of respiratory failure soon after birth. This is most likely due to abnormal development of peripheral nerves that control breathing movement.
MATERIALS AND METHODS

Generation and characterization of SMIT-1 knockout mice
The targeting vector was constructed by replacing a 680 bp sequence near the 5′-end of the SMIT-1 coding region with the positive selection marker PGKNeo r , removing amino acid 176 to 404 of SMIT-1. The vector also contained the negative selection marker HSVtk. Embryonic stem (ES) cells (AB2.2) were transfected with the target vector, and cells resistant to G418 and FIAU were selected and screened by PCR. PCR primers pA (5′-ATCAGCAGCCTCTGTTCCAC-3′) and R3 (5′-TGGATGTCTTTGATGAAGCC-3′) amplified a 400 bp fragment spanning PGKNeo r and exon 2 of SMIT-1. PCR primers F5 (5′-GATGGCATGGATCTGTAGAC-3′) and pMT (5′-CTGCTAAAGCGCATGCTC-3′) amplified a 300 bp fragment containing part of HSVtk and part of SMIT-1. ES cells containing the PGKNeo r sequence, but without the HSVtk sequence, were then screened by Southern blot hybridization by digesting the genomic DNA with Stu I and probing with a 1 kb Pst I fragment of exon 2. ES cells with the targeted allele integrated into the chromosome by homologous recombination were injected into C57BL/6 blastocysts to generate chimeric founders, and germline transmission was identified by their agouti coat color, and confirmed by PCR and Southern blot hybridization. PCR primers F2 (5′-ATGACTGCTTTGCTGACTGT-3′) and R3 amplified a 1 kb fragment of exon 2. This PCR product indicates the presence of the wild-type allele. The expression of SMIT-1 transcript was determined by Northern blot hybridization. Total RNA was extracted from kidney and brain of adult mice, and the SMIT-1 mRNA was identified by hybridizing the RNA gel blot with a Stu I and Sma I fragment in the coding region of SMIT-1 as a probe.
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Nerve imaging and analysis
The thy1-YFP transgenic mouse line 16 (16; Jackson Laboratory, Bar Harbor, ME) was bred with the SMIT-1 knockout mice line 4038. All of the mice used in this study were heterozygous for the thy1-YFP transgene. E13.5 and E18.5 fetuses were dissected and examined under a fluorescence stereomicroscope MZ FLIII (Leica, Germany), connected to a DC500 camera (Leica, Germany) and a computer. The time of exposure and magnification were optimized specifically for each type of nerve, but the same condition was applied to samples for each type of nerve from different genotypes. The pattern and fluorescence intensity of these nerves from embryos of different genotypes were compared. Four grades were given to the nerve according to its fluorescence intensity. Grade ++++ was considered as the strongest intensity, while grade + was considered as the weakest intensity.
Determination of nerve conduction velocity
Nerve conduction velocity (NCV) was determined as described previously by Song et al. (17) . Male adult (10±1 wk) mice were anesthetized with 0.01 ml/g body wt of Hypnorm (Janssen, Oxford, UK) and Dormicum (Hoffmann-La Roche, Natley, NJ). Body temperature was monitored with a rectal thermistor and controlled automatically within 37.5 ± 0.1°C by laying the animal on a heating pad. The sciatic nerve was stimulated proximally (at the level of sciatic notch) and distally (at the level of ankle) with platinum needle electrodes (Grass, Quincy, MA). Compound muscle action potentials were recorded from the ipsilateral foot between digits 2 and 3, amplified (Grass), stored, and displayed on a computer (Spike 2; CED, Cambridge, UK). After the measurements, the sciatic nerve was dissected and the distance between the stimulating electrodes was measured. The NCV is defined as the distance between the points of stimulation divided by the difference between the proximal and the distal latencies, and expressed in meter/second (m/s).
Determination MI levels by HPLC
To determine the MI concentration in various tissues of adult male mice (10±1 wk), a pair of sciatic nerves, whole brain, left kidney, gastrocnemius with soleus muscle, and liver were dissected out and stored at −80°C until processed. Carbohydrates were extracted from these organs by the method of Song et al. (17) . Carbohydrate extracts were separated on a DX500 HPLC system (Dionex, Sunnyvale, CA) equipped with a MA-1 analytical column with guard column and an ED40 electrochemical detector. Peak integration was performed using the Dionex Peaknet Software, and the MI level was quantified against a known standard and normalized with a known amount of xylitol as an internal control, which was added to the tissues before extraction. The concentration was expressed in nanomoles per milligram wet weight (nmol/mg).
PKC activity
The PKC activity in the sciatic nerve was assayed using a PKC enzyme assay kit (Amersham Biosciences). In brief, samples were homogenized in homogenizing buffer (50 mM Tris-HCl pH 7.5, 5 mM EDTA, 10 mM EGTA, 0.3% β-mercaptoethanol, protease inhibitor). The homogenate was centrifuged at 100 g for 10 min at 4°C. The supernatant was collected for the following experiment. One microliter of the supernatant was used for the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). Two micrograms of protein were diluted to 25 μl with homogenizing buffer. This solution was mixed with 25 μl of component mixture (a mixture of equal volume of calcium buffer, lipid, peptide buffer and DTT buffer provided in the kit) and 5 μl of the magnesium [ 32 P]ATP buffer. After being incubated at 37°C for 15 min, the reaction was terminated by the addition of 10 μl of stop reagent. Then, the solution was mixed thoroughly and 35 μl of the terminated reaction mixture was transferred onto the center of a paper disc. The disc was allowed to dry for at least 5 min before being washed with 75 mM orthophosphoric acid for 5 min twice. Finally, 10 ml of scintillant was added to paper disc and counted for 60 s in a scintillation counter (Beckman). The PKC activity was expressed as picomoles phosphate transferred per minute per microgram of protein (pmol/min/μg protein).
Statistical analysis
All data are mean ± SEM. Statistical analysis was performed by either the Student t test or oneway ANOVA; P < 0.05 was considered statistically significant.
RESULTS
Development of SMIT-1 gene knockout mice
In mice, as well as in humans, the entire coding region of SMIT-1 is contained within exon 2. The gene-targeting vector was constructed with 680 bp at the 5′end of SMIT-1 coding region replaced by the PGKNeo r gene, removing amino acids 176-404 of SMIT-1 (Fig. 1A) . Two lines of SMIT-1 knockout mice were generated from two independent ES cell clones (4038 and 4050). Heterozygous siblings of the SMIT-1 knockout mice were mated with each other, and the genotypes of their offspring were determined by PCR amplification ( (Table 1) . Thus, only ~20% of the expected number of SMIT −/− mice was present at the time of weaning when the genotype of the mice was determined, indicating that SMIT-1 deficiency may lead to prenatal or neonatal lethality in some mice. It is of interest that in subsequent breeding of this line of mice no SMIT −/− mice were found at weaning, suggesting that the lethality of SMIT-1 deficiency may be modulated by other genes. For line 4050, the number of SMIT +/+ , SMIT +/− , and SMIT −/− mice at weaning was 11, 32, and 0, respectively (Table 1) . Thus, the under representation of the SMIT −/− genotype occurred in two lines of SMIT-1 knockout mice derived from two independently isolated ES cells, indicating that the lethality is attributed to SMIT-1 deficiency and not due to mutations in the ES cells generated in the process of gene targeting. Brain and kidney total RNA were extracted from the 6-to 8-wk old wild-type and line 4038 SMIT −/− mice and analyzed by Northern blot hybridization. As shown in Fig. 1D , the 10.5 kb SMIT-1 transcript was absent in the kidneys and the brains of the SMIT-1 null mice, indicating that the gene was inactivated by homologous recombination with the targeting vector.
SMIT-1 null mice died of respiratory failure soon after birth
To determine whether the SMIT-1 null mice died in utero or after birth, pregnant heterozygous 4038 females, impregnated by heterozygous 4038 males, were killed at embryonic day 18.5 (E18.5), <1 day before natural delivery, and the fetuses were collected and genotyped. (Table 1) . This suggests that the SMIT −/− mice were able to survive throughout the entire period of embryonic development, and they probably died soon after birth. The delivery of the pups was closely monitored, and it was observed that soon after birth some of them appeared to have difficulty breathing. Their skin turned cyanotic color, and they died within a few minutes. Eight dead neonates were collected, and they were found to be all of the SMIT −/− genotype, suggesting that SMIT-1 deficiency causes respiratory dysfunction and neonatal lethality.
Light microscopic examination of the paraffin embedded sections of the lungs of the dead neonates and that of their healthy littermates revealed that the air sacs of the lungs of all except one of the SMIT −/− neonates were closed, whereas the air sacs of all the SMIT +/+ neonates were opened (Fig. 2) . Otherwise, the structure of the SMIT −/− lungs appeared normal. Since the collapsed lung air sacs in the SMIT −/− neonates could be due to the time lapsed between death and sample collection, lungs of E18.5 fetuses were examined. The air sacs of all the SMIT +/+ lungs were opened, whereas that of ~80% of the SMIT −/− lungs appeared closed.
Neonatal lethality of the SMIT-1 null mice was prevented by prenatal maternal MI supplement
Since there are other transporters that can facilitate the cellular uptake of MI, albeit less efficiently, we therefore determined if maternal dietary MI supplement could prevent neonatal lethality of the SMIT-1 null mice. 
SMIT
−/− neonates. However, there was no beneficial effect when the treatment began at E15.5
( Table 1 ), indicating that between E9.5 and E15.5 is the period of development that required high level of MI and critical for survival.
Examination of lung sections revealed that prenatal maternal MI supplement started at E0.5 or E9.5 normalized the lung morphology of the E18.5 SMIT −/− fetuses, whereas MI supplement starting at E15.5 had no effect (Fig. 2) . Thus, the collapsed air sacs closely correlate with neonatal lethality of the SMIT −/− mice, further supporting the notion that the cause of death is respiratory failure. The closed air sacs in the SMIT −/− lungs could be due to immature lung development or impairment in breathing control leading to lack of fetal breathing. Determination of the mRNA levels of lung surfactant proteins A, C, and D revealed that there was no difference in the expression of these genes that are expressed at the final stages of lung development, suggesting that SMIT-1 deficiency did not significantly affect lung development (data not shown).
SMIT-1 deficiency impaired the development of peripheral nerves
To facilitate the visualization of nerve fibers in the mouse embryos, the thy1-YFP transgene that specifically express the yellow fluorescence protein in the neurons (16) was introduced into the line 4038 SMIT-1 null mice. The expression of YFP made the nerve fibers visible under fluorescent microscopy without staining for nerve-specific proteins. The phrenic nerve that innervates the diaphragm is one of the most important nerves for the control of breathing. In the E18.5 wild-type or SMIT +/− fetuses, a pair of phrenic nerves running from the neck to the diaphragm was clearly visible (Fig. 3) . However, in 27/47 of the SMIT −/− fetuses studied, the phrenic nerve was absent; in 12/47 only the left side phrenic was present; in 2/47 only the right one was visible, and in 6/47 both nerves were present. Further, the phrenic nerves in the SMIT-1 null fetuses, even when present, showed much weaker fluorescence and fewer branches than that of the wild-type (Table 2 ). To determine if the reduced number and size of the phrenic nerve was due to retarded development or degeneration, the E13.5 fetuses were also examined. The results showed that underdevelopment of the phrenic nerves was already evident at E13.5 (data not shown), the earliest time when these nerves were examined, suggesting that the reduced number and size of the phrenic nerves in the E18.5 SMIT-1 deficient fetuses is the consequence of failure to develop rather than degeneration.
Other peripheral nerves in the E18.5 SMIT −/− fetuses examined, including the brachial plexus, facial, vagus, and the intercostal nerves, all appeared to be underdeveloped ( Fig. 4 ; Table 2 ), although, in general, their abnormalities appeared to be not as severe as that seen in the phrenic nerve. Examination of the E18.5 SMIT −/− fetuses from mothers receiving MI supplement showed normal development in all the above-mentioned peripheral nerves (Table 2 ). These results indicate that MI is essential for the development of peripheral nerves and that SMIT-1 deficiency leads to insufficient uptake of MI to support their development.
SMIT-1 deficiency reduced tissue MI content
To determine the effect of SMIT-1 deficiency and MI supplement on tissue MI content, MI was extracted from various tissues of the 10-wk-old SMIT −/− mice and their SMIT +/+ littermates. These mice received prenatal and postnatal maternal MI supplement. After being weaned (at 4 wk old), one group continued to receive MI supplement via its drinking water, while another
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group received no MI supplement. As shown in Table 3 , MI contents in the sciatic nerve, brain, kidney, skeletal muscle, and liver of the SMIT −/− mice were reduced to ~10, 39, 22, 24, and 38%, respectively, compared with that of the same tissues in their SMIT +/+ littermates. The residual MI could be from endogenous synthesis or uptake from the circulating fluid by other transporters. The dramatic decrease of MI indicates that import of MI from the circulating fluid is the major source of intracellular MI in these tissues. Postweaning MI supplement increased the MI contents of the sciatic nerve, brain, kidney, skeletal muscle, and liver of the SMIT-1 null mice by 25, 4.2, 7.9, 391, and 69%, respectively (Table 3) .
SMIT-1 deficiency impaired NCV and reduced PKC activity of the sciatic nerve
To determine if MI depletion affects the function of the peripheral nerves, NCV of the sciatic nerve of the 10-wk-old SMIT −/− and SMIT +/+ mice was measured. One group of mice received postweaning MI supplement, and one group did not. As shown in Fig. 5A , NCV in SMIT −/− mice was dramatically reduced, and MI supplement partially restored it. SMIT-1 deficiency also reduced the PKC activity in the sciatic nerve. MI supplement increased the PKC activity slightly, but the difference was not statistically significant (Fig. 5B ).
DISCUSSION
We developed two lines of SMIT-1 gene knockout mice and found that the homozygous SMIT-1 null mice died of respiratory failure soon after birth. Although the lung air sacs were closed, the structure of their lungs appeared to be well developed. Further, the normal expression of the lung surfactant proteins suggests that SMIT-1 deficiency does not significantly affect lung development. The closed air sacs probably reflect the absence of fetal breathing. The development of the peripheral nerves, including the phrenic nerve, which is crucial for regulating the movement of the diaphragm, was severely impaired by SMIT-1 deficiency, indicating that MI is important for the development of these nerves and that respiratory failure is due to malformation of the nerves controlling breathing. This is supported by the fact that prenatal maternal MI supplement restored peripheral nerve development and prevented neonatal lethality.
It is interesting that MI supplement beginning at E0.5 or E9.5 was able to prevent neonatal lethality, whereas supplement beginning at E15.5 could not. This corresponds well with the time of embryonic peripheral nerve development in mice. It has been shown that axons of the phrenic nerve exit the spinal cord and extend its fibers along the thorax to reach the developing diaphragm at E12. By E13.5, the branches of the phrenic nerves are formed and neuromuscular junctions with the diaphragm are established (18) (19) (20) . Therefore, MI supplement at E15.5 missed the critical period of phrenic nerve development and failed to prevent neonatal lethality.
Restoration of peripheral nerve development of the SMIT −/− fetuses by maternal MI supplement indicates that MI can be transferred across the placenta. This also indicates that other transporters in the SMIT −/− embryo can facilitate the uptake of MI when the plasma level of MI is high. The 1% dietary MI supplement has been shown to increase plasma MI level by 3-to 5.5-fold in rats (21) . In mammals, three different MI cotransporters were identified, namely SMIT-1, SMIT-2, and HMIT (H + /MI symporter). The amino acid sequence of SMIT-2 is 43% identical to that of SMIT-1, and its RNA was detected in brain, kidney, heart, skeletal muscle, spleen, liver, placenta, lung, leukocytes, and neurons (22) (23) (24) . The K m of SMIT-2 for MI is ~120 μM (22) , about twice as high as that of SMIT-1 (25) . HMIT, a symporter that couples protons and MI (26), does not share any amino acid sequence homology with SMIT-1. The K m of HMIT for MI is ~100 μM. HMIT is predominantly expressed in the brain (26) . The relative contribution of these MI transporters to the uptake of MI in various tissues is not clear. In wild-type mice, sciatic nerve, brain and kidney have levels of MI >10 fold higher than that seen in skeletal muscle and liver, suggesting a greater need of this metabolite in these tissues. SMIT-1 deficiency reduced the MI levels in the sciatic nerve, brain, and kidney by 90, 60, and 78%, respectively, indicating that these tissues are most dependent on SMIT-1 for their cellular MI content. It is difficult to obtain sufficient amount of embryonic peripheral nerves to determine their MI content. If they have similar dependency on SMIT-1 as the adult sciatic nerve, it might explain why the development of peripheral nerves is most sensitive to SMIT-1 deficiency.
Interestingly, postweaning MI supplement only increased MI levels in the sciatic nerve slightly, from 10 to 12.5% of that of the wild type, indicating that other transporters contribute to only small amounts of MI uptake in this tissue. If this is also true in embryonic peripheral nerves, it would suggest that the MI level in the peripheral nerves of the SMIT −/− fetuses is only marginally below the minimum level required for their development, and only a small increase in MI level is sufficient to normalize their development. Perhaps, this explains the observation that in the early breeding of line 4038 mice, ~20% of the SMIT −/− mice survived to adulthood without prenatal MI supplement. Therefore, other "modifying genes" that affect the endogenous synthesis or uptake of MI could affect peripheral nerve development and survival. The wide range of severity in the malformation of the peripheral nerves is also in agreement with this notion.
MI is a precursor for the synthesis of PI, which, in turn, is a precursor of IP 3 . Several observations suggest that IP 3 is important for nerve development. Neurotrophins (NGF, BDNF) have been shown to induce the elevation of IP 3 levels in nerve endings in rat brain (27) . Further, IP 3 receptor was found to be enriched in the growth cones of neurons in chick dorsal root ganglia, where it regulates the release of Ca ++ stored in the endoplasmic reticulum to mediate nerve growth (28) . In rat embryos, SMIT-1 is highly expressed in neuronal and non-neuronal cells in the brain and spinal cord (29) . In the brain of SMIT-1 deficient mice there was no observable developmental abnormality because of the high level of MI from endogenous synthesis or uptake by other transporters. On the other hand, the dramatic reduction of MI level in the sciatic nerve suggests that the lack of SMIT-1 in sensory and motor neurons in the spinal cord might lead to insufficient amounts of MI to support adequate level of IP 3 synthesis, leading to retardation of peripheral nerve development.
The reduction of MI in the peripheral nerves of SMIT-1 null mice not only affects their development but also their function, as evidenced by the reduction of NCV. NCV reduction is also an indication of functional impairment in diabetic peripheral nerves. Depletion of MI leading to reduction of PKC and Na + /K + -ATPase activity has been postulated as a pathogenic mechanism of diabetic neuropathy (9, 10) . MI is a precursor for the synthesis of DAG, which is required for the activation of PKC. Therefore, reduction of MI would lead to reduction of PKC activity. However, this is a controversial hypothesis, because in diabetic patients and mice neuropathy is not always accompanied by nerve MI depletion (11, 17) . In the SMIT-1 mice, we found that MI depletion indeed leads to reduced PKC activity and slowing of NCV. Whether this pathogenic mechanism is generally applicable to diabetic neuropathy is not clear.
Another line of SMIT-1 gene knockout mice has been reported earlier (30) . These mice also exhibit neonatal lethality. With the use of electrophysiological probes, respiratory failure in these mice was attributed to malfunction in the control of breathing at the brainstem. We found no obvious structural abnormality in the brains or brainstems of the E18.5 SMIT −/− fetuses.
Although the severe defects in the peripheral nerve development most likely lead to respiratory failure, we cannot rule out a functional abnormality or subtle developmental irregularity in the brainstem that may also contribute to this lethal consequence of SMIT-1 deficiency.
Besides defects in the development of the peripheral nerves, the E18. 
